Literature DB >> 22239991

Extent of cancer of less than 50% in any prostate needle biopsy core: how many millimeters are there?

Rodolfo Montironi, Marina Scarpelli, Roberta Mazzucchelli, Liang Cheng, Antonio Lopez-Beltran, Francesco Montorsi.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22239991     DOI： 10.1016/j.eururo.2011.12.050

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  4 in total

Review 1.  Standardization of reporting discontinuous tumor involvement in prostatic needle biopsy: a systematic review.

Authors:  Min Lu; Shulin Wu; Chin-Lee Wu
Journal:  Virchows Arch       Date:  2021-01-06       Impact factor: 4.064

2.  Consensus statement with recommendations on active surveillance inclusion criteria and definition of progression in men with localized prostate cancer: the critical role of the pathologist.

Authors:  Rodolfo Montironi; Elizabeth H Hammond; Daniel W Lin; John L Gore; John R Srigley; Hema Samaratunga; Lars Egevad; Mark A Rubin; John Nacey; Laurence Klotz; Howard Sandler; Anthony L Zietman; Stuart Holden; Peter A Humphrey; Andrew J Evans; Brett Delahunt; Jesse K McKenney; Daniel Berney; Thomas M Wheeler; Arul Chinnaiyan; Lawrence True; Beatrice Knudsen; Jonathan I Epstein; Mahul B Amin
Journal:  Virchows Arch       Date:  2014-10-16       Impact factor: 4.064

3.  Predictive criteria of insignificant prostate cancer: what is the correspondence of linear extent to percentage of cancer in a single core?

Authors:  Athanase Billis; Maisa M Q Quintal; Leandro L L Freitas; Larissa B E Costa; Ubirajara Ferreira
Journal:  Int Braz J Urol       Date:  2015 Mar-Apr       Impact factor: 1.541

4.  MRI-directed biopsy for primary detection of prostate cancer in a population of 223 men: MRI In-Bore vs MRI-transrectal ultrasound fusion-targeted techniques.

Authors:  Maurizio Del Monte; Stefano Cipollari; Francesco Del Giudice; Martina Pecoraro; Marco Bicchetti; Emanuele Messina; Ailin Dehghanpour; Antonio Ciardi; Alessandro Sciarra; Carlo Catalano; Valeria Panebianco
Journal:  Br J Radiol       Date:  2021-10-05       Impact factor: 3.039
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.